The FDA issued an emergency use authorization (EUA) for the third vaccine for the prevention of coronavirus disease 2019 (COVID-19). The EUA allows the Janssen COVID-19 Vaccine to be distributed in the U.S for use in individuals 18 years of age and older.
Read more: FDA Issues Emergency Use Authorization for Third COVID-19 Vaccine
Saturday, February 27, 2021
Pharma Reviews: Govt allocates over Rs 10000 crores in PLI scheme for bulk drugs, medical devices to fulfill vision ...
... at the inauguration ceremony of India Pharma 2021 & India Medical Devices 2021 organized by FICCI along with Department of Pharmaceuticals, ...
Read more: Govt allocates over Rs 10000 crores in PLI scheme for bulk drugs, medical devices to fulfill vision ...
Read more: Govt allocates over Rs 10000 crores in PLI scheme for bulk drugs, medical devices to fulfill vision ...
Pharma Reviews: Social Empowerment to Vaccine Development: Why I Trust Private Sector, Not Anarchists, to Solve ...
A case in point is the Indian industry's effort to make India, earlier a net ... Success of India's IT services, pharma sector and automobile sectors are ...
Read more: Social Empowerment to Vaccine Development: Why I Trust Private Sector, Not Anarchists, to Solve ...
Read more: Social Empowerment to Vaccine Development: Why I Trust Private Sector, Not Anarchists, to Solve ...
Friday, February 26, 2021
Pharma Reviews: Liberalise regulatory system, particularly for drug approvals: Zydus Group Chairman to Govt
Zydus Group Chairman Pankaj R Patel said the pharma industry can grow to ... Addressing the inaugural session of ''The India Pharma 2021 & India ...
Read more: Liberalise regulatory system, particularly for drug approvals: Zydus Group Chairman to Govt
Read more: Liberalise regulatory system, particularly for drug approvals: Zydus Group Chairman to Govt
Pharma Reviews: Takeda launches mobile app for management of genetic diseases
Biopharmaceutical company Takeda India, (part of the Takeda Pharmaceutical Company Limited) on Friday launched an application for the ...
Read more: Takeda launches mobile app for management of genetic diseases
Read more: Takeda launches mobile app for management of genetic diseases
Pharma Reviews: Glenmark bags India Pharma Innovation of the Year Award
Mumbai: Pharma major, Glenmark Pharmaceuticals, has recently announced that the company has received the "India Pharma Innovation of the Year" ...
Read more: Glenmark bags India Pharma Innovation of the Year Award
Read more: Glenmark bags India Pharma Innovation of the Year Award
Pharma Reviews: The Indian pharma industry in need of fundamental reforms: EY-FICCI report
To reach $ 130 bn in size by 2030 from the current $42 bn the Indian pharmaceutical (pharma) industry will require to double the last decade's growth ...
Read more: The Indian pharma industry in need of fundamental reforms: EY-FICCI report
Read more: The Indian pharma industry in need of fundamental reforms: EY-FICCI report
US FDA News: FDA Statement on Vaccines and Related Biological Products Advisory Committee Meeting
Following a positive advisory committee meeting outcome regarding the Janssen Biotech Inc. COVID-19 vaccine, the U.S. Food and Drug Administration has informed the sponsor that it will rapidly work toward finalization and issuance of an emergency use authorization
Read more: FDA Statement on Vaccines and Related Biological Products Advisory Committee Meeting
Read more: FDA Statement on Vaccines and Related Biological Products Advisory Committee Meeting
US FDA News: FDA Approves First Treatment for Molybdenum Cofactor Deficiency Type A
FDA approves treatment for Molybdenum Cofactor Deficiency Type A, a rare metabolic disorder characterized by severe and rapidly progressive neurologic damage.
Read more: FDA Approves First Treatment for Molybdenum Cofactor Deficiency Type A
Read more: FDA Approves First Treatment for Molybdenum Cofactor Deficiency Type A
US FDA News: Coronavirus (COVID-19) Update: February 26, 2021
Coronavirus (COVID-19) Update: February 26, 2021
Read more: Coronavirus (COVID-19) Update: February 26, 2021
Read more: Coronavirus (COVID-19) Update: February 26, 2021
US FDA News: FDA Authorizes Marketing of Novel Device to Help Protect Athletes’ Brains During Head Impacts
FDA has authorized marketing of a new device intended to be worn around the neck of athletes aged 13 years and older during sports activities to aid in the protection of the brain from the effects associated with repetitive sub-concussive head impacts.
Read more: FDA Authorizes Marketing of Novel Device to Help Protect Athletes’ Brains During Head Impacts
Read more: FDA Authorizes Marketing of Novel Device to Help Protect Athletes’ Brains During Head Impacts
Pharma Reviews: Piyush Goyal Calls Upon Pharma, Healthcare Sectors to Adopt Best Quality Practices
... and Consumer Affairs and Food & Public Distribution Piyush Goyal has called upon the Indian pharmaceutical and healthcare sector to adopt best ...
Read more: Piyush Goyal Calls Upon Pharma, Healthcare Sectors to Adopt Best Quality Practices
Read more: Piyush Goyal Calls Upon Pharma, Healthcare Sectors to Adopt Best Quality Practices
Thursday, February 25, 2021
Pharma Reviews: COVID-19 remains a key trigger for pharma space, analysts pick these 15 stocks for medium term
The Indian pharma industry has evolved over the years and now boasts of the largest number of FDA-approved pharma units outside the United States.
Read more: COVID-19 remains a key trigger for pharma space, analysts pick these 15 stocks for medium term
Read more: COVID-19 remains a key trigger for pharma space, analysts pick these 15 stocks for medium term
Pharma Reviews: Honeywell to take affordable automation to SMEs
Honeywell India, a technology company, has launched a new business entity ... to Covid-19, but now has wider applications for the pharma industry.
Read more: Honeywell to take affordable automation to SMEs
Read more: Honeywell to take affordable automation to SMEs
Pharma Reviews: Govt working to reduce regulatory compliance burden on pharma sector, says Sadananda Gowda
''Indian pharma industry can achieve the ambitious target which it has set for itself, reaching an annual turnover of USD 130 billion by 2030. Similarly ...
Read more: Govt working to reduce regulatory compliance burden on pharma sector, says Sadananda Gowda
Read more: Govt working to reduce regulatory compliance burden on pharma sector, says Sadananda Gowda
Pharma Reviews: India has support of 57 WTO members for TRIPS waiver for access to Covid medicine: Commerce ...
He called upon the Indian pharmaceutical and health care sector to adopt best practices in terms of quality, facility and commitment to maintaining high ...
Read more: India has support of 57 WTO members for TRIPS waiver for access to Covid medicine: Commerce ...
Read more: India has support of 57 WTO members for TRIPS waiver for access to Covid medicine: Commerce ...
Pharma Reviews: T-Hub calls for applications for fifth batch of its flagship pre-acceleration Lab32 prog
PUNE, India, Feb. 25, 2021 /PRNewswire/ -- TÜV SÜD South Asia, a leading certification, testing, auditing, inspection and training company and the ...
Read more: T-Hub calls for applications for fifth batch of its flagship pre-acceleration Lab32 prog
Read more: T-Hub calls for applications for fifth batch of its flagship pre-acceleration Lab32 prog
Pharma Reviews: Govt to release guidelines on ₹150 billion pharma incentive scheme in March
Unlike the earlier PLI scheme which was aimed at boosting India's bulk drug security, the new scheme is aimed at encouraging the pharmaceutical ...
Read more: Govt to release guidelines on ₹150 billion pharma incentive scheme in March
Read more: Govt to release guidelines on ₹150 billion pharma incentive scheme in March
Pharma Reviews: Indian pharma must grow at 12% CAGR to be $130 billion in size by 2030
To reach that target from the current $42 billion, the Indian pharmaceutical industry will require to double the last decade's growth rate of 6% to 12%.
Read more: Indian pharma must grow at 12% CAGR to be $130 billion in size by 2030
Read more: Indian pharma must grow at 12% CAGR to be $130 billion in size by 2030
Pharma Reviews: Want to market the next Coronil? Here's a guide to selling untested ayurvedic drugs
Here are some tried and tested tricks, straight from the playbook of India's $10 billion ayurveda industry. ByRonak Borana 25 Feb, 2021.
Read more: Want to market the next Coronil? Here's a guide to selling untested ayurvedic drugs
Read more: Want to market the next Coronil? Here's a guide to selling untested ayurvedic drugs
Pharma Reviews: Fulfilling the vision of Aatmanirbhar Bharat, the government has allocated over Rs. 10000 crores in ...
Speaking at the inauguration ceremony of India Pharma 2021 & India ... The medical devices industry in India has the potential to grow at 28% p.a. to ...
Read more: Fulfilling the vision of Aatmanirbhar Bharat, the government has allocated over Rs. 10000 crores in ...
Read more: Fulfilling the vision of Aatmanirbhar Bharat, the government has allocated over Rs. 10000 crores in ...
Pharma Reviews: Govt working to improve ease of doing biz in pharma sector: Minister
"Indian pharma industry can achieve the ambitious target which it has set for itself for reaching an annual turnover of USD 130 billion by 2030.
Read more: Govt working to improve ease of doing biz in pharma sector: Minister
Read more: Govt working to improve ease of doing biz in pharma sector: Minister
Pharma Reviews: Govt working to reduce regulatory compliance burden on pharma sector: Sadananda Gowda
Addressing the inaugural session of 'The India Pharma 2021 & India ... "Indian pharma industry can achieve the ambitious target which it has set for ...
Read more: Govt working to reduce regulatory compliance burden on pharma sector: Sadananda Gowda
Read more: Govt working to reduce regulatory compliance burden on pharma sector: Sadananda Gowda
Pharma Reviews: Glenmark receives 'India Pharma Innovation of the Year' Award from the govt. of India
Mumbai (Maharashtra) [India], February 25 (ANI/PRNewswire): Glenmark Pharmaceuticals, a research-led, global integrated pharmaceutical company ...
Read more: Glenmark receives 'India Pharma Innovation of the Year' Award from the govt. of India
Read more: Glenmark receives 'India Pharma Innovation of the Year' Award from the govt. of India
Pharma Reviews: Cabinet decisions: Biggies to benefit from PLI for pharma, IT hardware
The Indian pharmaceutical industry is the third-largest globally in terms of the volume term of production and is worth $40 billion in value term.
Read more: Cabinet decisions: Biggies to benefit from PLI for pharma, IT hardware
Read more: Cabinet decisions: Biggies to benefit from PLI for pharma, IT hardware
Pharma Reviews: India's proposal at WTO for TRIPS waiver gets support from 57 nations, says Piyush Goyal
Speaking at the sixth edition of the International Conference on Pharmaceuticals and Medical Devices Industry - 'India 2021 and India Medical ...
Read more: India's proposal at WTO for TRIPS waiver gets support from 57 nations, says Piyush Goyal
Read more: India's proposal at WTO for TRIPS waiver gets support from 57 nations, says Piyush Goyal
Pharma Reviews: Govt continuously working to improve ease of doing business in pharma sector: Minister
Addressing the inaugural session of ''The India Pharma 2021 & India ... "Indian pharma industry can achieve the ambitious target which it has set for ...
Read more: Govt continuously working to improve ease of doing business in pharma sector: Minister
Read more: Govt continuously working to improve ease of doing business in pharma sector: Minister
Pharma Reviews: Govt continuously working to improve ease of doing biz in pharma sector, says Sadananda Gowda
Addressing the inaugural session of 'The India Pharma 2021 & India ... “Indian pharma industry can achieve the ambitious target which it has set for ...
Read more: Govt continuously working to improve ease of doing biz in pharma sector, says Sadananda Gowda
Read more: Govt continuously working to improve ease of doing biz in pharma sector, says Sadananda Gowda
Pharma Reviews: Piyush Goyal addressed the 6th International Conference on Pharmaceutical & Medical Device ...
... and Consumer Affairs and Food & Public Distribution Shri Piyush Goyal today called upon the Indian pharmaceutical and health care sector to adopt ...
Read more: Piyush Goyal addressed the 6th International Conference on Pharmaceutical & Medical Device ...
Read more: Piyush Goyal addressed the 6th International Conference on Pharmaceutical & Medical Device ...
Pharma Reviews: India seen golden period for healthcare in last few years: Piyush Goyal
New Delhi, Feb 25 (ANI): Union Minister Piyush Goyal while addressing International Conference on Pharmaceuticals and Medical Devices Industry ...
Read more: India seen golden period for healthcare in last few years: Piyush Goyal
Read more: India seen golden period for healthcare in last few years: Piyush Goyal
Pharma Reviews: India's proposal at the WTO for TRIPS waiver to allow more countries to get equitable access to ...
Addressing the 6th International Conference on Pharmaceutical & Medical Devices Sector, he said that we all should collectively ensure that the nation ...
Read more: India's proposal at the WTO for TRIPS waiver to allow more countries to get equitable access to ...
Read more: India's proposal at the WTO for TRIPS waiver to allow more countries to get equitable access to ...
Pharma Reviews: RBI Governor Shaktikanta Das speaks on petrol, diesel prices, economy, MSME scope and much ...
He said healthcare sector has attained new heights during the pandemic and the global demand for Indian pharma companies has increased.
Read more: RBI Governor Shaktikanta Das speaks on petrol, diesel prices, economy, MSME scope and much ...
Read more: RBI Governor Shaktikanta Das speaks on petrol, diesel prices, economy, MSME scope and much ...
Pharma Reviews: Coronavirus News Live Updates: India reports 16738 new COVID-19 cases; highest since January ...
Commerce and Industry Minister Piyush Goyal on Thursday expressed hope that global pharmaceutical industry will show "big heart" and support India's ...
Read more: Coronavirus News Live Updates: India reports 16738 new COVID-19 cases; highest since January ...
Read more: Coronavirus News Live Updates: India reports 16738 new COVID-19 cases; highest since January ...
Pharma Reviews: Coronavirus: Latest updates on COVID-19 crisis around the world
... Industry Minister Piyush Goyal on Thursday expressed hope that global pharmaceutical industry will show 'big heart' and support India's proposal in ...
Read more: Coronavirus: Latest updates on COVID-19 crisis around the world
Read more: Coronavirus: Latest updates on COVID-19 crisis around the world
Wednesday, February 24, 2021
Pharma Reviews: Realisation there in pharma industry to become self reliant in API production: IPA
, noted that Indian industry had the know-how to produce APIs but somehow lost the advantage to countries like China. "Reliance on China for APIs is ...
Read more: Realisation there in pharma industry to become self reliant in API production: IPA
Read more: Realisation there in pharma industry to become self reliant in API production: IPA
Pharma Reviews: Govt okays ₹22325 cr sops plan for pharma, IT hardware sectors
The move will boost local manufacturing and reduce India's dependence on ... The Indian pharma industry, the third-largest in the world by volume, ...
Read more: Govt okays ₹22325 cr sops plan for pharma, IT hardware sectors
Read more: Govt okays ₹22325 cr sops plan for pharma, IT hardware sectors
Pharma Reviews: Realisation there in pharma industry to become self reliant in API production: IPA
IPA, which represents 24 leading research-based drug firms including Sun Pharma, Dr Reddy's, Cipla and Lupin, noted that Indian industry had the ...
Read more: Realisation there in pharma industry to become self reliant in API production: IPA
Read more: Realisation there in pharma industry to become self reliant in API production: IPA
Pharma Reviews: In conversation with Rajiv Nath, MD, Hindustan Syringes & Medical Devices Ltd.
As India geared up to fight the COVID crisis, the Association of Indian Medical Device Industry relentlessly worked at the forefront to combat the crisis.
Read more: In conversation with Rajiv Nath, MD, Hindustan Syringes & Medical Devices Ltd.
Read more: In conversation with Rajiv Nath, MD, Hindustan Syringes & Medical Devices Ltd.
Pharma Reviews: Prime Minister Acknowledges The Role Of Private Sector in Parliament, Does that mean very soon ...
And the fact that today India is being able to aid other countries in the world in providing vaccines, the credit for the same goes to the pharma companies ...
Read more: Prime Minister Acknowledges The Role Of Private Sector in Parliament, Does that mean very soon ...
Read more: Prime Minister Acknowledges The Role Of Private Sector in Parliament, Does that mean very soon ...
Pharma Reviews: Indian pharma firms go local seeking to end reliance on China
NEW DELHI: Indian drug companies are looking to local makers of so-called active pharmaceutical ingredients (API) or trying to make them in-house ...
Read more: Indian pharma firms go local seeking to end reliance on China
Read more: Indian pharma firms go local seeking to end reliance on China
Pharma Reviews: Union Cabinet approves Production Linked Incentive Scheme for Pharmaceuticals
The scheme will be part of the umbrella scheme for the Development of Pharmaceutical Industry. The objective of the scheme is to enhance India's ...
Read more: Union Cabinet approves Production Linked Incentive Scheme for Pharmaceuticals
Read more: Union Cabinet approves Production Linked Incentive Scheme for Pharmaceuticals
Pharma Reviews: Market LIVE Updates: Sensex pares back from 50k, NSE halts trading due to glitch
Indian benchmark equity indices Sensex and Nifty opened marginally ... Pharma company Sanofi India Ltd's register of members and share transfer ...
Read more: Market LIVE Updates: Sensex pares back from 50k, NSE halts trading due to glitch
Read more: Market LIVE Updates: Sensex pares back from 50k, NSE halts trading due to glitch
Tuesday, February 23, 2021
Pharma Reviews: Seeking to end reliance on China, Indian pharma firms go local for APIs
New Delhi: Indian drug companies are looking to local makers of so-called active pharmaceutical ingredients (API) or trying to make them in-house in a ...
Read more: Seeking to end reliance on China, Indian pharma firms go local for APIs
Read more: Seeking to end reliance on China, Indian pharma firms go local for APIs
Pharma Reviews: Rakesh Jhunjhunwala is bullish on Indian IT and pharma, but not in favour of internet companies
Ace investor Rakesh Jhunjhunwala says the Indian IT industry will be a world leader for a long long time to come and it will post profitable growth.
Read more: Rakesh Jhunjhunwala is bullish on Indian IT and pharma, but not in favour of internet companies
Read more: Rakesh Jhunjhunwala is bullish on Indian IT and pharma, but not in favour of internet companies
US FDA News: Medtronic Announces Voluntary Recall of Unused Valiant Navion™ Thoracic Stent Graft System
Medtronic plc , the global leader in medical technology, has voluntarily issued a global recall of unused Medtronic Valiant Navion™ thoracic stent graft system and informed physicians to immediately cease use of the device until further notice.
Read more: Medtronic Announces Voluntary Recall of Unused Valiant Navion™ Thoracic Stent Graft System
Read more: Medtronic Announces Voluntary Recall of Unused Valiant Navion™ Thoracic Stent Graft System
Pharma Reviews: Govt to implement 4-pronged health strategy, says PM
He, however, expressed disappointment on the pharma sector's dependence on imports for raw materials. The Indian Express is now on Telegram.
Read more: Govt to implement 4-pronged health strategy, says PM
Read more: Govt to implement 4-pronged health strategy, says PM
US FDA News: Coronavirus (COVID-19) Update: February 23, 2021
Coronavirus (COVID-19) Update: February 23, 2021
Read more: Coronavirus (COVID-19) Update: February 23, 2021
Read more: Coronavirus (COVID-19) Update: February 23, 2021
Pharma Reviews: Telangana aims to make life sciences a $100 billion industry
The Indian Council for Medical Research (ICMR) is also establishing the country's largest National Animal Resource facility for biomedical research in ...
Read more: Telangana aims to make life sciences a $100 billion industry
Read more: Telangana aims to make life sciences a $100 billion industry
Pharma Reviews: Indian origin pharma executive gets over 3-year jail for fraud sales
New York: An Indian-origin pharmaceutical executive has been sentenced by a federal judge in Texas to 41 months in prison for fraudulently selling ...
Read more: Indian origin pharma executive gets over 3-year jail for fraud sales
Read more: Indian origin pharma executive gets over 3-year jail for fraud sales
Pharma Reviews: 'Speculation of Highest Order': Rakesh Jhunjhunwala Says Centre Should Ban Cryptocurrencies
Indian Pharma Firms Go Local Seeking to End Reliance on China · Executives at India's Cadila Healthcare, Cipla, Sun Pharmaceutical and Biocon said ...
Read more: 'Speculation of Highest Order': Rakesh Jhunjhunwala Says Centre Should Ban Cryptocurrencies
Read more: 'Speculation of Highest Order': Rakesh Jhunjhunwala Says Centre Should Ban Cryptocurrencies
Pharma Reviews: Brokerages name these six buying ideas for an upside of 13-40%
India exports pharmaceuticals worth over $20 billion annually. The government has budgeted Rs 13,000 crore for RoDTEP to reimburse embedded ...
Read more: Brokerages name these six buying ideas for an upside of 13-40%
Read more: Brokerages name these six buying ideas for an upside of 13-40%
Pharma Reviews: Varavara Rao Gets Interim Bail on Medical Grounds in Surjagarh Iron Ore Mine Arson Case
Indian drug companies are looking to local makers of so-called active pharmaceutical ingredients (API) or trying to make them in-house in a bid to end ...
Read more: Varavara Rao Gets Interim Bail on Medical Grounds in Surjagarh Iron Ore Mine Arson Case
Read more: Varavara Rao Gets Interim Bail on Medical Grounds in Surjagarh Iron Ore Mine Arson Case
Pharma Reviews: Indian pharma firms go local seeking to end reliance on China
NEW DELHI : Indian drug companies are looking to local makers of so-called active pharmaceutical ingredients (API) or trying to make them in-house ...
Read more: Indian pharma firms go local seeking to end reliance on China
Read more: Indian pharma firms go local seeking to end reliance on China
Pharma Reviews: Govt. of Telangana partners with Cytiva to strengthen the biopharma industry in India with new lab
Combined, they contribute about 35% of India's pharmaceutical production. Cytiva's Fast Trak lab is ready to meet the area's fast-growing demand.
Read more: Govt. of Telangana partners with Cytiva to strengthen the biopharma industry in India with new lab
Read more: Govt. of Telangana partners with Cytiva to strengthen the biopharma industry in India with new lab
Pharma Reviews: KTR inaugurates BioAsia, lauds Hyderabad for vaccine efforts
Mr Rao emphasised, “on the pharma industry front, we remain committed to grounding the Hyderabad Pharma City project soon to support India's ...
Read more: KTR inaugurates BioAsia, lauds Hyderabad for vaccine efforts
Read more: KTR inaugurates BioAsia, lauds Hyderabad for vaccine efforts
Monday, February 22, 2021
Pharma Reviews: TPC Packaging, subsidiary of Global Cold Chain Solutions Australia, opens second factory in ...
The company plans to build more in the coming year to support the growth of the Indian pharmaceutical and biological manufacturers. The opening is ...
Read more: TPC Packaging, subsidiary of Global Cold Chain Solutions Australia, opens second factory in ...
Read more: TPC Packaging, subsidiary of Global Cold Chain Solutions Australia, opens second factory in ...
Pharma Reviews: Dr Rajeev Singh Raghuvanshi appointed Secretary-cum-Scientific Director of Indian ...
Express Pharma, first published as Express Pharma Pulse in 1994, is today India's leading business fortnightly for the pharmaceutical industry. With the ...
Read more: Dr Rajeev Singh Raghuvanshi appointed Secretary-cum-Scientific Director of Indian ...
Read more: Dr Rajeev Singh Raghuvanshi appointed Secretary-cum-Scientific Director of Indian ...
US FDA News: Hillrom Recalls Liko Multirall 200 Overhead Lift Due to Failure to Properly Attach Q-Link Strap Lock (Also Known as Q-Link 1 Strap Lock) to S65 Hook
The Liko Multirall 200 Overhead Lift is a general-purpose lift to move patients from room to room.
Read more: Hillrom Recalls Liko Multirall 200 Overhead Lift Due to Failure to Properly Attach Q-Link Strap Lock (Also Known as Q-Link 1 Strap Lock) to S65 Hook
Read more: Hillrom Recalls Liko Multirall 200 Overhead Lift Due to Failure to Properly Attach Q-Link Strap Lock (Also Known as Q-Link 1 Strap Lock) to S65 Hook
US FDA News: Coronavirus (COVID-19) Update: FDA Issues Policies to Guide Medical Product Developers Addressing Virus Variants
Coronavirus (COVID-19) Update: FDA Issues Policies to Guide Medical Product Developers Addressing Virus Variants
Read more: Coronavirus (COVID-19) Update: FDA Issues Policies to Guide Medical Product Developers Addressing Virus Variants
Read more: Coronavirus (COVID-19) Update: FDA Issues Policies to Guide Medical Product Developers Addressing Virus Variants
Pharma Reviews: Telangana govt to ground Hyderabad pharma city project soon to support India's Pharma Industry
... Feb 22 (UNI) Telangana government was strongly committed to ground the Hyderabad Pharma City project soon to support India's pharma industry ...
Read more: Telangana govt to ground Hyderabad pharma city project soon to support India's Pharma Industry
Read more: Telangana govt to ground Hyderabad pharma city project soon to support India's Pharma Industry
Pharma Reviews: Pandemic bolstered Hyderabad's role as vaccine capital of the world: KTR
Further, Aurobindo Pharma is building a world-class vaccine manufacturing ... “We also have Indian Council for Medical Research establishing the ...
Read more: Pandemic bolstered Hyderabad's role as vaccine capital of the world: KTR
Read more: Pandemic bolstered Hyderabad's role as vaccine capital of the world: KTR
Pharma Reviews: TPC Packaging, subsidiary of Global Cold Chain Solutions Australia, opens second factory in ...
The company plans to build more in the coming year to support the growth of the Indian pharmaceutical and biological manufacturers. Image-2-(1). The ...
Read more: TPC Packaging, subsidiary of Global Cold Chain Solutions Australia, opens second factory in ...
Read more: TPC Packaging, subsidiary of Global Cold Chain Solutions Australia, opens second factory in ...
Saturday, February 20, 2021
Pharma Reviews: Only boycott of British goods won't do — Why Abdul Hamied went on to create Cipla
Instead of promoting the development of India's chemical industry, Britain sent ... The route to his longed-for pharmaceutical research laboratory took ...
Read more: Only boycott of British goods won't do — Why Abdul Hamied went on to create Cipla
Read more: Only boycott of British goods won't do — Why Abdul Hamied went on to create Cipla
Pharma Reviews: 'Those who write recipes forget the role of biochemistry in it'
The spectacular success of the Indian pharma industry, having become a major player in affordable healthcare, is clearly another thing worth ...
Read more: 'Those who write recipes forget the role of biochemistry in it'
Read more: 'Those who write recipes forget the role of biochemistry in it'
Pharma Reviews: AP needs State-specific bulk drug policy
JAWAHARLAL Nehru Pharama City (JNPC), a sector-specific pharma industrial park, the biggest in India, developed by Ramky Pharma City (India) ...
Read more: AP needs State-specific bulk drug policy
Read more: AP needs State-specific bulk drug policy
Friday, February 19, 2021
US FDA News: FDA Warns 10 Companies for Illegally Selling Dietary Supplements Claiming to Treat Depression and Other Mental Health Disorders
FDA announced warning letters to 10 companies for illegally selling dietary supplements that claim to cure, treat, mitigate, or prevent depression and other mental health disorders, in violation of the Federal Food, Drug, and Cosmetic Act (FD&C Act).
Read more: FDA Warns 10 Companies for Illegally Selling Dietary Supplements Claiming to Treat Depression and Other Mental Health Disorders
Read more: FDA Warns 10 Companies for Illegally Selling Dietary Supplements Claiming to Treat Depression and Other Mental Health Disorders
US FDA News: Boston Scientific Corporation Recalls EMBLEM S-ICD (Subcutaneous Implantable Cardioverter Defibrillator) System Due to Risk of Short-Circuit
EMBLEM S-ICD is an implantable defibrillator. In some devices, moisture may get inside and keep the device from shocking the heart to fix heart rhythm.
Read more: Boston Scientific Corporation Recalls EMBLEM S-ICD (Subcutaneous Implantable Cardioverter Defibrillator) System Due to Risk of Short-Circuit
Read more: Boston Scientific Corporation Recalls EMBLEM S-ICD (Subcutaneous Implantable Cardioverter Defibrillator) System Due to Risk of Short-Circuit
US FDA News: Coronavirus (COVID-19) Update: February 19, 2021
Coronavirus (COVID-19) Update: February 19, 2021
Read more: Coronavirus (COVID-19) Update: February 19, 2021
Read more: Coronavirus (COVID-19) Update: February 19, 2021
US FDA News: Pulse Oximeter Accuracy and Limitations: FDA Safety Communication
The FDA is informing patients and health care providers that pulse oximeters have limitations and a risk of inaccuracy that must be considered.
Read more: Pulse Oximeter Accuracy and Limitations: FDA Safety Communication
Read more: Pulse Oximeter Accuracy and Limitations: FDA Safety Communication
Pharma Reviews: Market LIVE Updates: Sensex tumbles 550 pts, Nifty below 15K; PSU banks fall
Aurobindo Pharma has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Droxidopa Capsules, 100 ...
Read more: Market LIVE Updates: Sensex tumbles 550 pts, Nifty below 15K; PSU banks fall
Read more: Market LIVE Updates: Sensex tumbles 550 pts, Nifty below 15K; PSU banks fall
Thursday, February 18, 2021
Pharma Reviews: Lot Of Concerns About Behaviour Of Big Tech Firms: Goyal
Amid a row with Twitter over blocking of accounts, India has also warned ... sector, he said some US pharma companies are unhappy about India's ...
Read more: Lot Of Concerns About Behaviour Of Big Tech Firms: Goyal
Read more: Lot Of Concerns About Behaviour Of Big Tech Firms: Goyal
US FDA News: COVID-19 Update: USDA, FDA Underscore Current Epidemiologic and Scientific Information Indicating No Transmission of COVID-19 Through Food or Food Packaging
USDA, FDA underscore epidemiologic and scientific information indicating no transmission of COVID-19 Through Food or Food Packaging
Read more: COVID-19 Update: USDA, FDA Underscore Current Epidemiologic and Scientific Information Indicating No Transmission of COVID-19 Through Food or Food Packaging
Read more: COVID-19 Update: USDA, FDA Underscore Current Epidemiologic and Scientific Information Indicating No Transmission of COVID-19 Through Food or Food Packaging
Pharma Reviews: Market LIVE Updates: Indices trade in the red with Nifty around 15150; PSU banks rally, auto drags
... for telecom gear manufacturing in India. Nifty sectoral indices were trading mixed, with Nifty PSU Bank index gaining 3.3 percent while Nifty Pharma ...
Read more: Market LIVE Updates: Indices trade in the red with Nifty around 15150; PSU banks rally, auto drags
Read more: Market LIVE Updates: Indices trade in the red with Nifty around 15150; PSU banks rally, auto drags
Wednesday, February 17, 2021
US FDA News: FDA Approves First in the World, First-of-Its-Kind Implant for the Treatment of Rare Bone Disease as a Humanitarian Use Device
FDA approved the Patient Specific Talus Spacer, a first in the world and first-of-its-kind 3D-printed implant to replace the talus—the bone in the ankle joint that connects the leg and the foot—for the treatment of avascular necrosis (AVN) of the ankle joint.
Read more: FDA Approves First in the World, First-of-Its-Kind Implant for the Treatment of Rare Bone Disease as a Humanitarian Use Device
Read more: FDA Approves First in the World, First-of-Its-Kind Implant for the Treatment of Rare Bone Disease as a Humanitarian Use Device
Pharma Reviews: Lot of concerns about behaviour of big tech firms: Piyush Goyal
Replying to a question about increasing collaboration in the healthcare sector, he said some US pharma companies are unhappy about India's desire ...
Read more: Lot of concerns about behaviour of big tech firms: Piyush Goyal
Read more: Lot of concerns about behaviour of big tech firms: Piyush Goyal
Tuesday, February 16, 2021
Pharma Reviews: MARKET LIVE: Indices recover; Sensex down 100 pts; pharma, IT stocks slide
Stock market live updates: The Indian markets were trading weak on Wednesday, tracking similar cues from their Asian peers. The S&P BSE Sensex ...
Read more: MARKET LIVE: Indices recover; Sensex down 100 pts; pharma, IT stocks slide
Read more: MARKET LIVE: Indices recover; Sensex down 100 pts; pharma, IT stocks slide
US FDA News: Adamssecret.co Issues Voluntary Nationwide Recall of Adam’s Secret Extra Strength 1500 and 3000 Capsules Due to Presence of Undeclared Sildenafil and/or Tadalafil
Adamssecret.co is voluntarily recalling all lots within expiry of Adam’s Secret Extra Strength 1500 and Adam’s Secret Extra Strength 3000 capsules to the consumer level. This recall has been initiated after an FDA laboratory analysis found the product to contain undeclared sildenafil and/or tadalafi
Read more: Adamssecret.co Issues Voluntary Nationwide Recall of Adam’s Secret Extra Strength 1500 and 3000 Capsules Due to Presence of Undeclared Sildenafil and/or Tadalafil
Read more: Adamssecret.co Issues Voluntary Nationwide Recall of Adam’s Secret Extra Strength 1500 and 3000 Capsules Due to Presence of Undeclared Sildenafil and/or Tadalafil
Pharma Reviews: Beta Drugs Launches 'Adsunib' the First Indian Brand of Sunitinib
Apart from Sunitinib, the company was the first to launch Axitinib and Lenvatinib that strengthens the company's portfolio in Renal Cell Carcinoma ...
Read more: Beta Drugs Launches 'Adsunib' the First Indian Brand of Sunitinib
Read more: Beta Drugs Launches 'Adsunib' the First Indian Brand of Sunitinib
Pharma Reviews: Exclusive | India pushes post-Brexit UK for easier visa norms, lower trade barriers
... practices limiting drug manufacturing by Indian firms based in Britain, as the first steps to close a proposed bilateral trade pact, according to sources.
Read more: Exclusive | India pushes post-Brexit UK for easier visa norms, lower trade barriers
Read more: Exclusive | India pushes post-Brexit UK for easier visa norms, lower trade barriers
Monday, February 15, 2021
Pharma Reviews: Indian tech sector grows 2.3%, adds 1.38 lakh jobs in FY21: Nasscom
Mumbai: The Indian IT industry revenues are set to grow by 2.3 per cent to USD 194 billion in FY2020-21 and the exports will go up by 1.9 per cent to ...
Read more: Indian tech sector grows 2.3%, adds 1.38 lakh jobs in FY21: Nasscom
Read more: Indian tech sector grows 2.3%, adds 1.38 lakh jobs in FY21: Nasscom
Pharma Reviews: OPINION | Why Every Indian Must Wholeheartedly Support PM Modi's Defence of Private Sector
The Pharma Revolution that India's Private Sector Created. The story of the rise of India's private sector-driven pharmaceutical industry goes along ...
Read more: OPINION | Why Every Indian Must Wholeheartedly Support PM Modi's Defence of Private Sector
Read more: OPINION | Why Every Indian Must Wholeheartedly Support PM Modi's Defence of Private Sector
Pharma Reviews: Cyber resilience: A high priority
Indian pharma companies are witnessing major cyber threats as they ... Data breaches, cyber-attacks on pharma and healthcare companies, who are ...
Read more: Cyber resilience: A high priority
Read more: Cyber resilience: A high priority
Pharma Reviews: Serum Institute to ship COVISHIELD to Canada in “'less than a month”
India boasts of several vaccine manufacturing facilities and is fast emerging as a key supplier to the world. Canada does not yet have a vaccine ...
Read more: Serum Institute to ship COVISHIELD to Canada in “'less than a month”
Read more: Serum Institute to ship COVISHIELD to Canada in “'less than a month”
Sunday, February 14, 2021
Pharma Reviews: Covid Vaccine can be a game changer for Indian Pharma Industry on a global platform
Covid Vaccine can be a game changer for Indian Pharma Industry on a global platform. Global economy (GDP), which was valued at 90 trillion USD ( ...
Read more: Covid Vaccine can be a game changer for Indian Pharma Industry on a global platform
Read more: Covid Vaccine can be a game changer for Indian Pharma Industry on a global platform
Saturday, February 13, 2021
Pharma Reviews: View: Can growing anti-China sentiments favour Indian overseas direct investment?
It is opening further overseas investment avenues for Indian Pharma companies. India cannot hope to compete for dollar-for-dollar with Chinese ...
Read more: View: Can growing anti-China sentiments favour Indian overseas direct investment?
Read more: View: Can growing anti-China sentiments favour Indian overseas direct investment?
Pharma Reviews: Indian pharma market expected to hit USD 130 billion by 2030: Sadananda Gowda
"The total market size of the Indian pharma industry is expected to reach USD 130 billion by 2030. The medical devices industry in India has the potential ...
Read more: Indian pharma market expected to hit USD 130 billion by 2030: Sadananda Gowda
Read more: Indian pharma market expected to hit USD 130 billion by 2030: Sadananda Gowda
Friday, February 12, 2021
Pharma Reviews: Glenmark's consolidated net profit rises by 30.05% to Rs. 2481.79 Mn. in Q3 FY 2020-21
Mumbai (Maharashtra) [India], February 13 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited, a research-led global integrated pharmaceutical ...
Read more: Glenmark's consolidated net profit rises by 30.05% to Rs. 2481.79 Mn. in Q3 FY 2020-21
Read more: Glenmark's consolidated net profit rises by 30.05% to Rs. 2481.79 Mn. in Q3 FY 2020-21
Pharma Reviews: Glenmarks consolidated Net Profit rises by 30.05% to Rs. 2481.79 Mn. in Q3 FY 2020-21
Glenmark Pharmaceuticals Limited, a research-led global integrated ... with growth of 15.8% as compared to IPM (Indian Pharma market) growth of ...
Read more: Glenmarks consolidated Net Profit rises by 30.05% to Rs. 2481.79 Mn. in Q3 FY 2020-21
Read more: Glenmarks consolidated Net Profit rises by 30.05% to Rs. 2481.79 Mn. in Q3 FY 2020-21
Pharma Reviews: 'Udyog Manthan' organised to deliberate on ways to enhance productivity, quality in major sectors ...
Kumar said that to become "self-reliant India", "we have to increase the competitiveness among our Indian industries. We need to focus on productivity ...
Read more: 'Udyog Manthan' organised to deliberate on ways to enhance productivity, quality in major sectors ...
Read more: 'Udyog Manthan' organised to deliberate on ways to enhance productivity, quality in major sectors ...
US FDA News: FDA Approves Drug to Reduce Bone Marrow Suppression Caused by Chemotherapy
The FDA approved Cosela (trilaciclib) as the first therapy in its class to reduce the frequency of chemotherapy-induced bone marrow suppression in adults receiving certain types of chemotherapy for extensive-stage (when the cancer has spread beyond the lungs) small cell lung cancer.
Read more: FDA Approves Drug to Reduce Bone Marrow Suppression Caused by Chemotherapy
Read more: FDA Approves Drug to Reduce Bone Marrow Suppression Caused by Chemotherapy
Pharma Reviews: UK-India bilateral trade could rise to £50 billion from the existing £24 billion
... 1,500 high-skilled jobs to sites across the UK and Indian pharmaceutical and biotechnology giant Wockhardt creating 40 new jobs in Wrexham.
Read more: UK-India bilateral trade could rise to £50 billion from the existing £24 billion
Read more: UK-India bilateral trade could rise to £50 billion from the existing £24 billion
Pharma Reviews: Cargo Service Center launches real-time temp tracking app TURANT
February 12, 2021: The Indian air cargo ground handling company Cargo ... We are happy to be associated with the Indian pharmaceutical industry ...
Read more: Cargo Service Center launches real-time temp tracking app TURANT
Read more: Cargo Service Center launches real-time temp tracking app TURANT
Pharma Reviews: UK-India bilateral trade could rise to £50 billion: Report
... from top Indian businesses – with Tata Consultancy Services bringing 1,500 high-skilled jobs to sites across the UK and Indian pharmaceutical and ...
Read more: UK-India bilateral trade could rise to £50 billion: Report
Read more: UK-India bilateral trade could rise to £50 billion: Report
Pharma Reviews: Stock Market Highlights: Sensex, Nifty end flat; rise 1% for the week; banks outperform
Closing Bell | The Indian indices ended flat on Friday after rising in early deals as FMCG, energy, pharma and metal stocks declined. However, a rise ...
Read more: Stock Market Highlights: Sensex, Nifty end flat; rise 1% for the week; banks outperform
Read more: Stock Market Highlights: Sensex, Nifty end flat; rise 1% for the week; banks outperform
Pharma Reviews: Public Private Partnerships: The Panacea for Indian Healthcare Sector
Gujarat pharma co raided for falsely branding drugs. Sunlovis Pharmaceuticals LLP and Pravin Ramsang Chaudhari, one of its fi ve partners, were ...
Read more: Public Private Partnerships: The Panacea for Indian Healthcare Sector
Read more: Public Private Partnerships: The Panacea for Indian Healthcare Sector
Thursday, February 11, 2021
Pharma Reviews: India 'pharmacy to world' but sector is fragmented, unorganised — foreign firms' lobby says
As many as 26 top foreign drugmakers have given their suggestions for the Indian pharmaceutical industry and also highlighted its strengths and ...
Read more: India 'pharmacy to world' but sector is fragmented, unorganised — foreign firms' lobby says
Read more: India 'pharmacy to world' but sector is fragmented, unorganised — foreign firms' lobby says
Pharma Reviews: US acquires 200 mn more Covid vaccine doses
India's Biological E looking to make 600 mn J&J vaccine shots a year: CEO. Indian pharmaceutical company Biological E Ltd is looking to contract- ...
Read more: US acquires 200 mn more Covid vaccine doses
Read more: US acquires 200 mn more Covid vaccine doses
Pharma Reviews: 'Udyog Manthan' organised to deliberate on ways to enhance productivity, quality in major sectors ...
New Delhi [India], February 12 (ANI): The 8-week long 'Udyog Manthan' organised ... issues of productivity and quality in major sectors of Indian industry. ... various sectors including pharma, medical devices, closed-circuit camera, ...
Read more: 'Udyog Manthan' organised to deliberate on ways to enhance productivity, quality in major sectors ...
Read more: 'Udyog Manthan' organised to deliberate on ways to enhance productivity, quality in major sectors ...
Pharma Reviews: Industry must live up to expectations: India Inc after PM Modi's remarks on private sector
The Prime Minister had cited the examples of telecom and pharma sectors to note as to how the robust presence of private firms in these fields has ...
Read more: Industry must live up to expectations: India Inc after PM Modi's remarks on private sector
Read more: Industry must live up to expectations: India Inc after PM Modi's remarks on private sector
Pharma Reviews: The Brexit effect
The UK is an important market for the Indian pharma industry as every fourth tablet sold in the UK is from India. Diversifying the supply chain is important ...
Read more: The Brexit effect
Read more: The Brexit effect
Pharma Reviews: Indian pharma firm told to pay Rs 363 crore fine for destroying records before USFDA inspection
Washington: An Indian drug manufacturer has agreed to plead guilty to concealing and destroying records prior to a 2013 US Food and Drug ...
Read more: Indian pharma firm told to pay Rs 363 crore fine for destroying records before USFDA inspection
Read more: Indian pharma firm told to pay Rs 363 crore fine for destroying records before USFDA inspection
Pharma Reviews: Biological E eyeing to make 600 Million doses of Johnson and Johnson Covid-19 Vaccine per year
New Delhi: Indian pharmaceutical company Biological E Ltd is looking to ... by Bharat Biotech with the state-run Indian Council of Medical Research.
Read more: Biological E eyeing to make 600 Million doses of Johnson and Johnson Covid-19 Vaccine per year
Read more: Biological E eyeing to make 600 Million doses of Johnson and Johnson Covid-19 Vaccine per year
Pharma Reviews: Share Market LIVE: Sensex resumes upward march, closes 222 pts higher, Nifty ends above ...
Reliance Industries, Sun Pharma, and Bharti Airtel were up more than 2% each. ... Nippon India Nifty 50 Value 20 Index Fund expected to have lower ...
Read more: Share Market LIVE: Sensex resumes upward march, closes 222 pts higher, Nifty ends above ...
Read more: Share Market LIVE: Sensex resumes upward march, closes 222 pts higher, Nifty ends above ...
Wednesday, February 10, 2021
Pharma Reviews: TCS, Wockhardt lead UK's big Indian investment wins
"Life Sciences has been a priority sector for both nations, with UK pharmaceuticals exports to India growing by 21.4 per cent to 96.75 million pounds in ...
Read more: TCS, Wockhardt lead UK's big Indian investment wins
Read more: TCS, Wockhardt lead UK's big Indian investment wins
Pharma Reviews: Parliament LIVE Updates: Union Budget did little to reassure farmers on MSP, says Shashi Tharoor ...
Take any sector- telecommunications, pharmaceuticals - we see the role of the private sector. If India is able to serve humanity, it is also due to the role ...
Read more: Parliament LIVE Updates: Union Budget did little to reassure farmers on MSP, says Shashi Tharoor ...
Read more: Parliament LIVE Updates: Union Budget did little to reassure farmers on MSP, says Shashi Tharoor ...
Pharma Reviews: Govt to shut 2 pharma PSUs, disinvest Hindustan Antibiotics, 2 other: Minister informs Parliament
The government has offered voluntary retirement benefits to all employees of Indian Drugs & Pharmaceuticals Ltd (IDPL) and Rajasthan Drugs ...
Read more: Govt to shut 2 pharma PSUs, disinvest Hindustan Antibiotics, 2 other: Minister informs Parliament
Read more: Govt to shut 2 pharma PSUs, disinvest Hindustan Antibiotics, 2 other: Minister informs Parliament
Pharma Reviews: What changed for the market while you were sleeping? Top 10 things to know
Eicher Motors, Titan Company, GAIL India, Hindalco Industries, Aurobindo Pharma, ABB India, Asian Granito India, Bank of India, Bata India, BEML, ...
Read more: What changed for the market while you were sleeping? Top 10 things to know
Read more: What changed for the market while you were sleeping? Top 10 things to know
Pharma Reviews: Govt investing 3400 Cr to set-up 3 bulk drug & 4 medical device parks
The total market size of the Indian Pharma Industry is expected to reach US $ 130 Billion by 2030. The medical devices industry in India has the potential ...
Read more: Govt investing 3400 Cr to set-up 3 bulk drug & 4 medical device parks
Read more: Govt investing 3400 Cr to set-up 3 bulk drug & 4 medical device parks
Tuesday, February 9, 2021
Pharma Reviews: Budget 2021: Focus on the healthcare sector
The Indian economy has not been an exception, with the annual GDP ... Amid all these developments, the life sciences and pharma sector has been at ...
Read more: Budget 2021: Focus on the healthcare sector
Read more: Budget 2021: Focus on the healthcare sector
Pharma Reviews: Tata Consultancy Services, Wockhardt lead UK's big Indian investment wins
Life Sciences has been a priority sector for both nations, with UK pharmaceuticals exports to India growing by 21.4 per cent to 96.75 million pounds in ...
Read more: Tata Consultancy Services, Wockhardt lead UK's big Indian investment wins
Read more: Tata Consultancy Services, Wockhardt lead UK's big Indian investment wins
Pharma Reviews: TCS Wockhardt lead UK's big Indian investment wins
By Aditi Khanna London, Feb 10 (PTI) Indian technology major Tata Consultancy Services (TCS) and pharmaceutical and biotech major Wockhardt ...
Read more: TCS Wockhardt lead UK's big Indian investment wins
Read more: TCS Wockhardt lead UK's big Indian investment wins
Pharma Reviews: Rhizen Pharma gets US FDA accelerated approval for Umbralisib (UKONIQ) to treat relapsed or ...
Swaroop Vakkalanka, President & CEO of Rhizen Pharmaceuticals said, “We are keen to bring Umbralisib to Indian patients and we plan to initiate ...
Read more: Rhizen Pharma gets US FDA accelerated approval for Umbralisib (UKONIQ) to treat relapsed or ...
Read more: Rhizen Pharma gets US FDA accelerated approval for Umbralisib (UKONIQ) to treat relapsed or ...
Pharma Reviews: Unfulfilled potential
India's progress in the medicine and pharmaceutical sector has again come to limelight after the outbreak of the Coronavirus pandemic when 'quinine' ...
Read more: Unfulfilled potential
Read more: Unfulfilled potential
Pharma Reviews: India orders 14.5 million more Covid-19 vaccine doses as campaign expands
Indian pharma market expected to hit USD 130 billion by 2030: Sadananda Gowda. Pharmaceuticals are one of the top-10 attractive sectors for foreign ...
Read more: India orders 14.5 million more Covid-19 vaccine doses as campaign expands
Read more: India orders 14.5 million more Covid-19 vaccine doses as campaign expands
Pharma Reviews: Gainers & Losers: Top 10 stocks that moved the most on February 4
India's leading e-pharmacy company 1mg said it is investing in expansion of its cold chain, training thousands of vaccinators and is in touch with ...
Read more: Gainers & Losers: Top 10 stocks that moved the most on February 4
Read more: Gainers & Losers: Top 10 stocks that moved the most on February 4
US FDA News: Coronavirus (COVID-19) Update: FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19
Today, the FDA issued an emergency use authorization for two monoclonal antibodies administered together for the treatment of mild to moderate COVID-19 in adults and pediatric patients who are at high risk for progressing to severe COVID-19.
Read more: Coronavirus (COVID-19) Update: FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19
Read more: Coronavirus (COVID-19) Update: FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19
US FDA News: Using Ventilator Splitters During the COVID-19 Pandemic - Letter to Health Care Providers
The FDA is informing that recent literature indicates that certain features are associated with better performance.
Read more: Using Ventilator Splitters During the COVID-19 Pandemic - Letter to Health Care Providers
Read more: Using Ventilator Splitters During the COVID-19 Pandemic - Letter to Health Care Providers
Pharma Reviews: Explained: Where is the maximum employability gap?
We are seeing several industries where the employability gap is ever ... India is the largest provider of generic drugs globally and Indian companies ...
Read more: Explained: Where is the maximum employability gap?
Read more: Explained: Where is the maximum employability gap?
Pharma Reviews: Indian pharma industry expected to reach USD 130 billion by 2030: DV Sadananda Gowda
New Delhi: The Indian pharmaceutical industry has proved to be a dependable supplier of quality drugs in a time of global need on account of the ...
Read more: Indian pharma industry expected to reach USD 130 billion by 2030: DV Sadananda Gowda
Read more: Indian pharma industry expected to reach USD 130 billion by 2030: DV Sadananda Gowda
Pharma Reviews: Why Budget 2021 is a good start for Indian healthcare?
The pharma industry should use the opportunity to accelerate essential drugs and raise awareness towards preventive and curative aspects among the ...
Read more: Why Budget 2021 is a good start for Indian healthcare?
Read more: Why Budget 2021 is a good start for Indian healthcare?
Pharma Reviews: International Harmonising of the standards and specifications will boost the Medical devices ...
International Harmonising of the standards and specifications will boost the Medical devices Industry in India: Dr P B N Prasad. The government is ...
Read more: International Harmonising of the standards and specifications will boost the Medical devices ...
Read more: International Harmonising of the standards and specifications will boost the Medical devices ...
Pharma Reviews: Share Market Highlights: Sensex slips 19 points on closing, Nifty ends above 15100; M&M, Sun ...
Mahindra & Mahindra, Sun Pharma, and ITC were the top drags. ... suit changing customer needs, such as industry leader State Bank of India (SBI, ...
Read more: Share Market Highlights: Sensex slips 19 points on closing, Nifty ends above 15100; M&M, Sun ...
Read more: Share Market Highlights: Sensex slips 19 points on closing, Nifty ends above 15100; M&M, Sun ...
Monday, February 8, 2021
Pharma Reviews: Balaji Amines in demand after Q3 PAT spurts 162% YoY
Balaji Amines soared 15.49% to Rs 1461.20 after the company's ... as there is sustained growth of Indian pharma industry on account of 'China Plus ...
Read more: Balaji Amines in demand after Q3 PAT spurts 162% YoY
Read more: Balaji Amines in demand after Q3 PAT spurts 162% YoY
Pharma Reviews: Balaji Amines zooms 20%, hits fresh high on strong Q3 numbers
... of Indian pharma industry on account of 'China Plus One' business strategy ... Balaji Amines is a leading manufacturer of Aliphatic Amines in India.
Read more: Balaji Amines zooms 20%, hits fresh high on strong Q3 numbers
Read more: Balaji Amines zooms 20%, hits fresh high on strong Q3 numbers
Pharma Reviews: Indian pharma market expected to hit USD 130 bn by 2030: Gowda
New Delhi, Feb 8 (PTI) The Indian pharmaceutical industry has proved to be a dependable supplier of quality drugs in a time of global need on ...
Read more: Indian pharma market expected to hit USD 130 bn by 2030: Gowda
Read more: Indian pharma market expected to hit USD 130 bn by 2030: Gowda
Pharma Reviews: Pharma market to hit $130 billion by 2030: Gowda
“The total market size of the Indian pharma industry is expected to reach $130 billion by 2030. The medical devices industry in India has the potential to ...
Read more: Pharma market to hit $130 billion by 2030: Gowda
Read more: Pharma market to hit $130 billion by 2030: Gowda
Pharma Reviews: Indian pharma market expected to grow to USD 130 billion by 2030: Gowda
New Delhi [India], February 8 (ANI): Union Minister for Chemicals and Fertilizers, D V Sadananda Gowda said that the Indian pharma market is ...
Read more: Indian pharma market expected to grow to USD 130 billion by 2030: Gowda
Read more: Indian pharma market expected to grow to USD 130 billion by 2030: Gowda
Pharma Reviews: Indian pharma market is expected to grow to US$ 130 billion by 2030: DV Sadananda Gowda
The Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, jointly with FICCI & Invest India is organizing the 6th edition of annual program ...
Read more: Indian pharma market is expected to grow to US$ 130 billion by 2030: DV Sadananda Gowda
Read more: Indian pharma market is expected to grow to US$ 130 billion by 2030: DV Sadananda Gowda
Pharma Reviews: 6th Edition of 'India Pharma & India Medical Device 2021' on 25-26 Feb & 1-2 March 2021
The total market size of the Indian Pharma Industry is expected to reach the US $ 130 Billion by 2030. The medical devices industry in India has the ...
Read more: 6th Edition of 'India Pharma & India Medical Device 2021' on 25-26 Feb & 1-2 March 2021
Read more: 6th Edition of 'India Pharma & India Medical Device 2021' on 25-26 Feb & 1-2 March 2021
Pharma Reviews: International Harmonising of the standards & specifications will boost the Medical devices Industry ...
Dr. Prasad also encouraged for India to be a medical manufacturing hub including Generics and medical devices both. He further said that India has ...
Read more: International Harmonising of the standards & specifications will boost the Medical devices Industry ...
Read more: International Harmonising of the standards & specifications will boost the Medical devices Industry ...
Pharma Reviews: Indian pharma market expected to grow to $130 bn by 2030: Gowda
Speaking at the curtain raiser of 'India Pharma & India Medical Device 2021', an event organised by the Department of Pharmaceuticals, Ministry of ...
Read more: Indian pharma market expected to grow to $130 bn by 2030: Gowda
Read more: Indian pharma market expected to grow to $130 bn by 2030: Gowda
Pharma Reviews: MASSIVE! Market size of Indian Pharma Industry is expected to reach $130 Billion by 2030, sector ...
During the pandemic, Indian Pharma industries supplied the necessary medicines to over 120 countries while fulfilling the country's own needs," said ...
Read more: MASSIVE! Market size of Indian Pharma Industry is expected to reach $130 Billion by 2030, sector ...
Read more: MASSIVE! Market size of Indian Pharma Industry is expected to reach $130 Billion by 2030, sector ...
US FDA News: FDA Announces New Resource for Veterinarians and Pet Owners Interested in Clinical Field Studies of Animal Cells, Tissues, and Cell- and Tissue-Based Products
FDA provides resource for clinical field studies investigating Animal Cells, Tissues, and Cell- and Tissue-Based Products (ACTPs) providing animal owners, veterinarians, researchers and the public with information on clinical field studies being investigated for ACTPs in veterinary patients.
Read more: FDA Announces New Resource for Veterinarians and Pet Owners Interested in Clinical Field Studies of Animal Cells, Tissues, and Cell- and Tissue-Based Products
Read more: FDA Announces New Resource for Veterinarians and Pet Owners Interested in Clinical Field Studies of Animal Cells, Tissues, and Cell- and Tissue-Based Products
Pharma Reviews: Staying ahead of the game
The Indian chemicals industry is highly diversified covering more than 80,000 ... The per capita consumption of chemicals in India (excluding pharma) ...
Read more: Staying ahead of the game
Read more: Staying ahead of the game
Pharma Reviews: Indian pharma market expected to hit USD 130 bn by 2030: Gowda
The Indian pharmaceutical industry has proved to be a dependable supplier of quality drugs in a time of global need on account of the COVID-19 ...
Read more: Indian pharma market expected to hit USD 130 bn by 2030: Gowda
Read more: Indian pharma market expected to hit USD 130 bn by 2030: Gowda
Pharma Reviews: Indian Pharma Market Expected To Grow To $130 Billion By 2030: DV Sadananda Gowda
The medical devices industry in India has the potential to reach $ 50 bn by 2025. The 'India Pharma & India Medical Device 2021' will be the 6th edition ...
Read more: Indian Pharma Market Expected To Grow To $130 Billion By 2030: DV Sadananda Gowda
Read more: Indian Pharma Market Expected To Grow To $130 Billion By 2030: DV Sadananda Gowda
Sunday, February 7, 2021
Pharma Reviews: These 6 penny stocks are already up 40 percent in 2021
Indian equities have been trading higher this year. ... projects, it is almost past the hurdle of API (active pharmaceutical ingredient) capacity constraints.
Read more: These 6 penny stocks are already up 40 percent in 2021
Read more: These 6 penny stocks are already up 40 percent in 2021
Pharma Reviews: Indian Pharma exports grew by 12.43 percent to USD 17.57 billion during Apr-Dec 2021
India''s exports of pharmaceutical products have not declined and they are growing consistently, Minister of State for Commerce and Industry Hardeep ...
Read more: Indian Pharma exports grew by 12.43 percent to USD 17.57 billion during Apr-Dec 2021
Read more: Indian Pharma exports grew by 12.43 percent to USD 17.57 billion during Apr-Dec 2021
Saturday, February 6, 2021
Pharma Reviews: Why pharma has emerged as magnet for global investors?
That said, India holds a great volume in the United States generics market, which makes the Indian pharma sector more visible to the investors. China ...
Read more: Why pharma has emerged as magnet for global investors?
Read more: Why pharma has emerged as magnet for global investors?
Friday, February 5, 2021
US FDA News: FDA Approves New Treatment For Adults With Relapsed Or Refractory Large-B-Cell Lymphoma
FDA approves Breyanzi (lisocabtagene maraleucel), a cell-based gene therapy to treat adult patients with certain types of large B-cell lymphoma who have not responded to, or who have relapsed after, at least two other types of treatment.
Read more: FDA Approves New Treatment For Adults With Relapsed Or Refractory Large-B-Cell Lymphoma
Read more: FDA Approves New Treatment For Adults With Relapsed Or Refractory Large-B-Cell Lymphoma
US FDA News: FDA Authorizes Marketing of Novel Device to Reduce Snoring and Mild Obstructive Sleep Apnea in Patients 18 Years and Older
FDA authorizes marketing for the eXiteOSA, a device intended to reduce snoring and mild obstructive sleep apnea in patients 18 years and older
Read more: FDA Authorizes Marketing of Novel Device to Reduce Snoring and Mild Obstructive Sleep Apnea in Patients 18 Years and Older
Read more: FDA Authorizes Marketing of Novel Device to Reduce Snoring and Mild Obstructive Sleep Apnea in Patients 18 Years and Older
Pharma Reviews: Covid-19 vaccines: India to face a problem of plenty
“Post June, the Covid-19 vaccine market is going to be like a sanitiser ... Then an Indian company, Shantha Biotechnics, developed novel processes ... Of the five vaccines, three are in alliance with international pharma companies, ...
Read more: Covid-19 vaccines: India to face a problem of plenty
Read more: Covid-19 vaccines: India to face a problem of plenty
Pharma Reviews: Market LIVE Updates: Indices trade higher with Nifty around 14950; SBI gains 12%, auto stocks dip
Fitch Ratings forecasts the Indian telecom industry's mobile segment ... had a meeting with India's drugs regulator on Wednesday and the decision ...
Read more: Market LIVE Updates: Indices trade higher with Nifty around 14950; SBI gains 12%, auto stocks dip
Read more: Market LIVE Updates: Indices trade higher with Nifty around 14950; SBI gains 12%, auto stocks dip
Thursday, February 4, 2021
US FDA News: Coronavirus (COVID-19) Update: FDA Announces Advisory Committee Meeting to Discuss Janssen Biotech Inc.’s COVID-19 Vaccine Candidate
The FDA has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Feb. 26, 2021, to discuss the request for emergency use authorization (EUA) for a COVID-19 vaccine from Janssen Biotech Inc.
Read more: Coronavirus (COVID-19) Update: FDA Announces Advisory Committee Meeting to Discuss Janssen Biotech Inc.’s COVID-19 Vaccine Candidate
Read more: Coronavirus (COVID-19) Update: FDA Announces Advisory Committee Meeting to Discuss Janssen Biotech Inc.’s COVID-19 Vaccine Candidate
US FDA News: Coronavirus (COVID-19) Update: FDA Continues Important Work to Support Medical Product Development to Address New Virus Variants
FDA Continues Important Work to Support Medical Product Development to Address New Virus Variants
Read more: Coronavirus (COVID-19) Update: FDA Continues Important Work to Support Medical Product Development to Address New Virus Variants
Read more: Coronavirus (COVID-19) Update: FDA Continues Important Work to Support Medical Product Development to Address New Virus Variants
US FDA News: Xeljanz, Xeljanz XR (tofacitinib): Drug Safety Communication - Initial Safety Trial Results Find Increased Risk of Serious Heart-related Problems and Cancer with Arthritis and Ulcerative Colitis Medicine
The FDA is alerting the public that preliminary results from a safety clinical trial show an increased risk of serious heart-related problems and cancer with the arthritis and ulcerative colitis medicine Xeljanz, Xeljanz XR (tofacitinib) compared to tumor necrosis factor (TNF) inhibitors.
Read more: Xeljanz, Xeljanz XR (tofacitinib): Drug Safety Communication - Initial Safety Trial Results Find Increased Risk of Serious Heart-related Problems and Cancer with Arthritis and Ulcerative Colitis Medicine
Read more: Xeljanz, Xeljanz XR (tofacitinib): Drug Safety Communication - Initial Safety Trial Results Find Increased Risk of Serious Heart-related Problems and Cancer with Arthritis and Ulcerative Colitis Medicine
Wednesday, February 3, 2021
Pharma Reviews: Covid pandemic has forced all to rethink health strategies: Jai Ram
Addressing a webinar on 'Changing Landscape of Indian Pharma Sector' organised by the Confederation of Indian Industry (CII) from Shimla, Thakur ...
Read more: Covid pandemic has forced all to rethink health strategies: Jai Ram
Read more: Covid pandemic has forced all to rethink health strategies: Jai Ram
Pharma Reviews: Nifty Extends 'Dream Budget' Rally on India's Economic Growth Prospect
This will help expand India's pharmaceutical industry. We believe the largely unchanged tax rates, notwithstanding the absence of incentives to boost ...
Read more: Nifty Extends 'Dream Budget' Rally on India's Economic Growth Prospect
Read more: Nifty Extends 'Dream Budget' Rally on India's Economic Growth Prospect
US FDA News: Apotex Corp. Issues Voluntary Nationwide Recall of Enoxaparin Sodium Injection, USP Due to Mislabeling of Syringe Barrel Measurement Markings
Apotex Corp is voluntarily recalling two (2) batches of Enoxaparin Sodium Injection, USP to consumer level due to a packaging error resulting in some syringes barrels containing 150 mg/mL markings (corresponding to 120 mg/0.8mL strength) instead of 100 mg/mL markings (corresponding to 100 mg/mL stre
Read more: Apotex Corp. Issues Voluntary Nationwide Recall of Enoxaparin Sodium Injection, USP Due to Mislabeling of Syringe Barrel Measurement Markings
Read more: Apotex Corp. Issues Voluntary Nationwide Recall of Enoxaparin Sodium Injection, USP Due to Mislabeling of Syringe Barrel Measurement Markings
Pharma Reviews: TOWER Cold Chain partners with SpiceJet, EFL to move Covid-19 vaccines
TOWER rents containers to the pharmaceutical industry that are used to ... Senthil Shanmugam, CEO, EFL global & managing director, EFL INDIA, ...
Read more: TOWER Cold Chain partners with SpiceJet, EFL to move Covid-19 vaccines
Read more: TOWER Cold Chain partners with SpiceJet, EFL to move Covid-19 vaccines
Pharma Reviews: Higher budget allocation for healthcare a welcome move: Industry
Expressing similar sentiments, Indian Drug Manufacturers” Association (IDMA) Executive Director Ashok Madan said, “Health sector as a pillar of the ...
Read more: Higher budget allocation for healthcare a welcome move: Industry
Read more: Higher budget allocation for healthcare a welcome move: Industry
Pharma Reviews: Budget 2021: Research, innovation gets a boost
Today, India is a biotechnology and pharmaceuticals hot spot and a hub for manufacturing small molecule generics, vaccines, insulins and other ...
Read more: Budget 2021: Research, innovation gets a boost
Read more: Budget 2021: Research, innovation gets a boost
Pharma Reviews: “Pharma can collaborate with institutes to bring cost effective treatment in timely manner for NTDs ...
Dr Girish Dixit, Executive Director & Head - Eisai Pharmaceuticals India, Vishakhapatnam spoke to BioSpectrum about how the company is fighting ...
Read more: “Pharma can collaborate with institutes to bring cost effective treatment in timely manner for NTDs ...
Read more: “Pharma can collaborate with institutes to bring cost effective treatment in timely manner for NTDs ...
Pharma Reviews: Market LIVE: Sensex, Nifty near record highs; IndusInd Bank top gainer
Nifty Pharma index jumps 4%; Sun Pharma, Cipla hit 52-week highs. Share Via ... All Nifty broad market indices higher; India VIX rises over 3%.
Read more: Market LIVE: Sensex, Nifty near record highs; IndusInd Bank top gainer
Read more: Market LIVE: Sensex, Nifty near record highs; IndusInd Bank top gainer
Pharma Reviews: Market LIVE Updates: Sensex, Nifty trade near record high led by auto, pharma, metal stocks
Rupee Updates: Indian rupee is trading marginally higher at 72.92, amid buying seen in the domestic equity market with indices at record highs.
Read more: Market LIVE Updates: Sensex, Nifty trade near record high led by auto, pharma, metal stocks
Read more: Market LIVE Updates: Sensex, Nifty trade near record high led by auto, pharma, metal stocks
Tuesday, February 2, 2021
Pharma Reviews: Budget 2021: Pharma sector sees higher spend on healthcare as positive, but some expectations ...
The Indian pharmaceutical industry finds itself in a Catch-22 situation. It is elated about the government's higher spend on healthcare in Budget 2021, ...
Read more: Budget 2021: Pharma sector sees higher spend on healthcare as positive, but some expectations ...
Read more: Budget 2021: Pharma sector sees higher spend on healthcare as positive, but some expectations ...
US FDA News: Boston Scientific Recalls EMBLEM S-ICD Subcutaneous Electrode (Model 3501) Due to Risk of Fractures
EMBLEM S-ICD Subcutaneous Electrode (Model 3501) is part of the Boston Scientific S-ICD System that helps detect heart activity and provides defibrillation therapy.
Read more: Boston Scientific Recalls EMBLEM S-ICD Subcutaneous Electrode (Model 3501) Due to Risk of Fractures
Read more: Boston Scientific Recalls EMBLEM S-ICD Subcutaneous Electrode (Model 3501) Due to Risk of Fractures
Pharma Reviews: Indian Exports Grow By 5.4% In Jan 2021; Drugs & Pharma Record 16.4% Hike Amid Coronavirus
A sector that has recorded a substantial increase in exports is drugs and pharmaceuticals which has witnessed a 16.4 percent YoY hike for January ...
Read more: Indian Exports Grow By 5.4% In Jan 2021; Drugs & Pharma Record 16.4% Hike Amid Coronavirus
Read more: Indian Exports Grow By 5.4% In Jan 2021; Drugs & Pharma Record 16.4% Hike Amid Coronavirus
Pharma Reviews: Higher budget allocation for healthcare a welcome move: Industry
The pharma and healthcare industry has welcomed the government's ... In a similar vein,Indian Pharmaceutical Alliance (IPA)Secretary-General ...
Read more: Higher budget allocation for healthcare a welcome move: Industry
Read more: Higher budget allocation for healthcare a welcome move: Industry
Pharma Reviews: Indian COVID Vaccine Exports Ramped Up To Bridge Supply Gap
BioTecNika keeps you updated with incredible & Latest Information from the Biotech & Pharma Industry.
Read more: Indian COVID Vaccine Exports Ramped Up To Bridge Supply Gap
Read more: Indian COVID Vaccine Exports Ramped Up To Bridge Supply Gap
Monday, February 1, 2021
Pharma Reviews: Pharma sector reacts to Union Budget 2021
The Organisation of Pharmaceutical Producers of India (OPPI) welcomes ... The FY22 Budget is in line to support recovery of Indian economy while ...
Read more: Pharma sector reacts to Union Budget 2021
Read more: Pharma sector reacts to Union Budget 2021
Pharma Reviews: Industry calls Union Budget 2021-22 ambitious but awaits implementation
The Indian pharmaceutical industry needs strong incentive to invest in making India a pharma research hub for the country and the world." Suresh ...
Read more: Industry calls Union Budget 2021-22 ambitious but awaits implementation
Read more: Industry calls Union Budget 2021-22 ambitious but awaits implementation
Pharma Reviews: Budget gives 200% boost to pharma sector as govt looks to curb dependence on China
New Delhi: India's first post-pandemic Budget has provided a boost of nearly 200 per cent for developing the pharmaceutical sector to help the country ...
Read more: Budget gives 200% boost to pharma sector as govt looks to curb dependence on China
Read more: Budget gives 200% boost to pharma sector as govt looks to curb dependence on China
Pharma Reviews: India: Good Distribution Practices For Pharmaceutical Products
Rightly hailed as the 'Pharmacy to the World,' Indian pharma is home to over 3,000 manufacturers and ~10,500 manufacturing units, with domestic ...
Read more: India: Good Distribution Practices For Pharmaceutical Products
Read more: India: Good Distribution Practices For Pharmaceutical Products
Pharma Reviews: India has plenty of Coronavirus vaccines but few takers
India has the opposite problem: Plenty of shots, but a shortage of people ... at the All India Institute of Medical Sciences of Patna, in the eastern state of Bihar. ... by Bharat Biotech International, a private company based in Hyderabad.
Read more: India has plenty of Coronavirus vaccines but few takers
Read more: India has plenty of Coronavirus vaccines but few takers
Subscribe to:
Comments (Atom)